NCT04553692 2025-03-28Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed CancersIGM Biosciences, Inc.Phase 1 Terminated272 enrolled
NCT00543712 2022-12-13A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)Genentech, Inc.Phase 2 Terminated15 enrolled